BIONET Corp. (TPEX:1784)
79.50
-1.50 (-1.85%)
At close: Mar 27, 2026
BIONET Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 256.05 | 242.79 | 238.49 | 161.61 | 121.8 |
Short-Term Investments | 1,013 | 1,194 | 553.19 | 174.83 | 195.41 |
Trading Asset Securities | 131.77 | 137.41 | 113.52 | 99.99 | 65.5 |
Cash & Short-Term Investments | 1,401 | 1,574 | 905.2 | 436.44 | 382.71 |
Cash Growth | -11.03% | 73.94% | 107.41% | 14.04% | -1.31% |
Accounts Receivable | 295.47 | 300.86 | 283.02 | 237.61 | 191.97 |
Other Receivables | 12.77 | 9.66 | 4.46 | 2.72 | 4.05 |
Receivables | 308.24 | 310.52 | 287.48 | 240.33 | 196.02 |
Inventory | 125.85 | 81.34 | 55.54 | 46.7 | 79.34 |
Prepaid Expenses | 35.88 | 30.73 | 16.97 | 20.4 | 24.52 |
Other Current Assets | 0.02 | 2.43 | 3.08 | 4.13 | 3.1 |
Total Current Assets | 1,871 | 2,000 | 1,268 | 747.99 | 685.69 |
Property, Plant & Equipment | 695.4 | 596.02 | 503.88 | 510.92 | 515.2 |
Long-Term Investments | 403.32 | 4.92 | - | - | - |
Goodwill | - | 10.09 | 10.09 | 10.09 | 10.09 |
Other Intangible Assets | 30.99 | 18.04 | 22.83 | 24.89 | 29.47 |
Long-Term Deferred Tax Assets | 7.73 | 8.52 | 7.66 | 9.84 | 16.29 |
Other Long-Term Assets | 71.62 | 519.15 | 535.92 | 534.95 | 527.11 |
Total Assets | 3,080 | 3,156 | 2,349 | 1,839 | 1,784 |
Accounts Payable | 79.94 | 63.49 | 67.78 | 58.1 | 55.73 |
Accrued Expenses | - | 126.05 | 115.87 | 100.12 | 75.49 |
Short-Term Debt | 70 | 65 | 30 | - | - |
Current Portion of Leases | 12.8 | 9.52 | 6.83 | 6.95 | 5.51 |
Current Income Taxes Payable | 0 | 22.67 | 23.1 | 8.49 | 4.97 |
Current Unearned Revenue | 82.17 | 64.13 | 51.04 | 45.88 | 73.2 |
Other Current Liabilities | 160.16 | 44.15 | 30.31 | 24.77 | 32.76 |
Total Current Liabilities | 405.07 | 395.01 | 324.92 | 244.3 | 247.66 |
Long-Term Leases | 31.01 | 19.77 | 6.04 | 6.09 | 7.83 |
Long-Term Unearned Revenue | 385.9 | 345.09 | 295.26 | 263.08 | 212.43 |
Long-Term Deferred Tax Liabilities | 0.61 | 0.53 | 0.25 | 0.5 | 0.27 |
Total Liabilities | 822.58 | 760.4 | 626.47 | 513.97 | 468.19 |
Common Stock | 531.21 | 531.21 | 496.27 | 496.27 | 496.27 |
Additional Paid-In Capital | 630.92 | 761.73 | 666.21 | 609.62 | 609.17 |
Retained Earnings | 102.91 | 125.36 | 110.94 | 67.42 | 53.38 |
Treasury Stock | -120.58 | -75.7 | -79.37 | -85.78 | -54.9 |
Comprehensive Income & Other | 127.57 | -7.98 | -6.42 | -6.36 | -6.53 |
Total Common Equity | 1,272 | 1,335 | 1,188 | 1,081 | 1,097 |
Minority Interest | 985.28 | 1,061 | 534.54 | 243.56 | 218.25 |
Shareholders' Equity | 2,257 | 2,396 | 1,722 | 1,325 | 1,316 |
Total Liabilities & Equity | 3,080 | 3,156 | 2,349 | 1,839 | 1,784 |
Total Debt | 113.8 | 94.28 | 42.86 | 13.04 | 13.34 |
Net Cash (Debt) | 1,287 | 1,480 | 862.33 | 423.4 | 369.37 |
Net Cash Growth | -13.05% | 71.65% | 103.67% | 14.63% | -1.51% |
Net Cash Per Share | 25.53 | 29.12 | 17.02 | 8.34 | 7.24 |
Filing Date Shares Outstanding | 50.13 | 50.83 | 50.65 | 50.28 | 51.13 |
Total Common Shares Outstanding | 50.13 | 50.83 | 50.65 | 50.28 | 51.13 |
Working Capital | 1,466 | 1,604 | 943.34 | 503.69 | 438.03 |
Book Value Per Share | 25.37 | 26.26 | 23.45 | 21.50 | 21.46 |
Tangible Book Value | 1,241 | 1,306 | 1,155 | 1,046 | 1,058 |
Tangible Book Value Per Share | 24.76 | 25.70 | 22.80 | 20.81 | 20.69 |
Land | - | 294 | 294 | 294 | 294 |
Buildings | - | 259.95 | 259.95 | 259.58 | 259.58 |
Machinery | - | 312.96 | 245.56 | 234.8 | 213.57 |
Construction In Progress | - | 22.6 | - | - | - |
Leasehold Improvements | - | 45.58 | 35.3 | 34.64 | 34.5 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.